174 related articles for article (PubMed ID: 29351960)
1. The Impact of Diabetes on Breast Cancer Treatments and Outcomes: A Population-Based Study.
Lega IC; Austin PC; Fischer HD; Fung K; Krzyzanowska MK; Amir E; Lipscombe LL
Diabetes Care; 2018 Apr; 41(4):755-761. PubMed ID: 29351960
[TBL] [Abstract][Full Text] [Related]
2. The association between diabetes and breast cancer stage at diagnosis: a population-based study.
Lipscombe LL; Fischer HD; Austin PC; Fu L; Jaakkimainen RL; Ginsburg O; Rochon PA; Narod S; Paszat L
Breast Cancer Res Treat; 2015 Apr; 150(3):613-20. PubMed ID: 25779100
[TBL] [Abstract][Full Text] [Related]
3. The influence of diabetes severity on receipt of guideline-concordant treatment for breast cancer.
Sabatino SA; Thompson TD; Wu XC; Fleming ST; Kimmick GG; Trentham-Dietz A; Cress R; Anderson RT
Breast Cancer Res Treat; 2014 Jul; 146(1):199-209. PubMed ID: 24899083
[TBL] [Abstract][Full Text] [Related]
4. Influence of Preexisting Diabetes on Survival After a Breast Cancer Diagnosis in First Nations Women in Ontario, Canada.
Sheppard AJ; Chiarelli AM; Hanley AJG; Marrett LD
JCO Glob Oncol; 2020 Feb; 6():99-107. PubMed ID: 32031452
[TBL] [Abstract][Full Text] [Related]
5. A retrospective cohort study of patients with stomach and liver cancers: the impact of comorbidity and ethnicity on cancer care and outcomes.
Sarfati D; Gurney J; Stanley J; Koea J
BMC Cancer; 2014 Nov; 14():821. PubMed ID: 25380581
[TBL] [Abstract][Full Text] [Related]
6. Preexisting Diabetes and Breast Cancer Treatment Among Low-Income Women.
Bekele BB; Lian M; Schmaltz C; Greever-Rice T; Shrestha P; Liu Y
JAMA Netw Open; 2024 May; 7(5):e249548. PubMed ID: 38717774
[TBL] [Abstract][Full Text] [Related]
7. Mortality impact of less-than-standard therapy in older breast cancer patients.
Yood MU; Owusu C; Buist DS; Geiger AM; Field TS; Thwin SS; Lash TL; Prout MN; Wei F; Quinn VP; Frost FJ; Silliman RA
J Am Coll Surg; 2008 Jan; 206(1):66-75. PubMed ID: 18155570
[TBL] [Abstract][Full Text] [Related]
8. Stage at diagnosis and comorbidity influence breast cancer survival in First Nations women in Ontario, Canada.
Sheppard AJ; Chiarelli AM; Marrett LD; Nishri ED; Trudeau ME
Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2160-7. PubMed ID: 21803843
[TBL] [Abstract][Full Text] [Related]
9. Metabolic comorbidities and the association with risks of recurrent metastatic disease in breast cancer survivors.
Anwar SL; Cahyono R; Prabowo D; Avanti WS; Choridah L; Dwianingsih EK; Harahap WA; Aryandono T
BMC Cancer; 2021 May; 21(1):590. PubMed ID: 34022845
[TBL] [Abstract][Full Text] [Related]
10. Diabetes and differences in detection of incident invasive breast cancer.
Calip GS; Yu O; Boudreau DM; Shao H; Oratz R; Richardson SB; Gold HT
Cancer Causes Control; 2019 May; 30(5):435-441. PubMed ID: 30949885
[TBL] [Abstract][Full Text] [Related]
11. Patterns of comorbidities in women with breast cancer: a Canadian population-based study.
Ng HS; Vitry A; Koczwara B; Roder D; McBride ML
Cancer Causes Control; 2019 Sep; 30(9):931-941. PubMed ID: 31280456
[TBL] [Abstract][Full Text] [Related]
12. Impact of Baseline Cardiovascular Comorbidity on Outcomes in Women With Breast Cancer: A Real-world, Population-based Study.
Abdel-Rahman O; Xu Y; Kong S; Dort J; Quan ML; Karim S; Bouchard-Fortier A; Cho H; Cheung WY
Clin Breast Cancer; 2019 Apr; 19(2):e297-e305. PubMed ID: 30630679
[TBL] [Abstract][Full Text] [Related]
13. Hyperthyroidism, Hypothyroidism, and Cause-Specific Mortality in a Large Cohort of Women.
Journy NMY; Bernier MO; Doody MM; Alexander BH; Linet MS; Kitahara CM
Thyroid; 2017 Aug; 27(8):1001-1010. PubMed ID: 28578598
[TBL] [Abstract][Full Text] [Related]
14. Associations between diabetes medication use and risk of second breast cancer events and mortality.
Calip GS; Yu O; Hoskins KF; Boudreau DM
Cancer Causes Control; 2015 Aug; 26(8):1065-77. PubMed ID: 25956271
[TBL] [Abstract][Full Text] [Related]
15. Low-Dose Aspirin Reduces Breast Cancer Risk in Women with Diabetes: A Nationwide Retrospective Cohort Study in Taiwan.
Yang YS; Kornelius E; Chiou JY; Lai YR; Lo SC; Peng CH; Huang CN
J Womens Health (Larchmt); 2017 Dec; 26(12):1278-1284. PubMed ID: 28537451
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant Chemotherapy Use and Health Care Costs After Introduction of Genomic Testing in Breast Cancer.
Epstein AJ; Wong YN; Mitra N; Vachani A; Hin S; Yang L; Smith-McLallen A; Armstrong K; Groeneveld PW
J Clin Oncol; 2015 Dec; 33(36):4259-67. PubMed ID: 26598749
[TBL] [Abstract][Full Text] [Related]
17. Diabetes mellitus and risk of breast cancer: a meta-analysis.
Larsson SC; Mantzoros CS; Wolk A
Int J Cancer; 2007 Aug; 121(4):856-62. PubMed ID: 17397032
[TBL] [Abstract][Full Text] [Related]
18. Impact of socio-economic status on breast cancer screening in women with diabetes: a population-based study.
Chan W; Yun L; Austin PC; Jaakkimainen RL; Booth GL; Hux J; Rochon PA; Lipscombe LL
Diabet Med; 2014 Jul; 31(7):806-12. PubMed ID: 24588332
[TBL] [Abstract][Full Text] [Related]
19. Ethnic differences in timely adjuvant chemotherapy and radiation therapy for breast cancer in New Zealand: a cohort study.
Seneviratne S; Campbell I; Scott N; Kuper-Hommel M; Round G; Lawrenson R
BMC Cancer; 2014 Nov; 14():839. PubMed ID: 25406582
[TBL] [Abstract][Full Text] [Related]
20. Impact of comorbidity on mortality: a cohort study of 62,591 Danish women diagnosed with early breast cancer, 1990-2008.
Land LH; Dalton SO; Jensen MB; Ewertz M
Breast Cancer Res Treat; 2012 Feb; 131(3):1013-20. PubMed ID: 22002567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
